Clinical evolution and survival of neurocritical patients.

Objective: To evaluate the clinical evolution and survival of neurocritical patients in Hospital Units.

Method: Cohort with hospitalized patients in follow-up treatment in public and private hospitals between September 2012 and June 2016. Data were initially analyzed from descriptive and inferential statistics. The Kaplan-Meier indicator was applied as a form of survival analysis. The Cox proportional hazards regression model was used to analyze the prognostic factors by calculating the hazard ratio.

Results: Participation of 1,289 patients in the study. Patients with a higher score on the Glasgow Coma Scale presented greater survival, and the one-point increase in the scale score corresponded to 42% improvement in their survival. In the analysis of survival, sex and the use of vasoactive drugs showed a significant difference.

Conclusion: Female patients with a better score on the Glasgow Coma Scale and using vasoactive drugs had higher survival rates.